Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-10

Clinical Trial Update: The Tatelo Plus Study [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial of Tatelo Plus for HIV infection is currently recruiting, sponsored by NIAID.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tatelo Plus

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV, HIV Infections | Phase 1, Phase 2 | Status: RECRUITING